相关实验视频

Updated: May 20, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

为免疫抑制微环境逆转和局部疫苗生成而设计的囊泡癌疫苗

Yang Li¹, Yulin Yu², Bin Xia³

¹Department of Pharmaceutics, Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.

Journal of controlled release : official journal of the Controlled Release Society

|March 23, 2025

概括

这项研究开发了一种新的纳米细菌疫苗 (dsRNA@NV_CD40L),以克服免疫抑制瘤微环境. 这增强了癌症免疫疗法,激活了免疫细胞,并引起了癌症疫苗在位免疫反应.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
纳米技术纳米技术

背景情况:

逆转免疫抑制瘤微环境 (TME) 对于有效的癌症免疫疗法至关重要.
德西塔治疗增加了瘤细胞抗原暴露和双链RNA (dsRNA) 积累,形成免疫性纳米微粒 (NV).
目前含dRNA的NV (dsRNA@NV) 疗效受到免疫抑制TME内免疫细胞激活不足的限制.

研究的目的:

通过在其表面加入CD40L来增强dsRNA@NV的疗效 (dsRNA@NV_CD40L).
研究dsRNA@NV_CD40L在逆转免疫抑制性TME和激活抗瘤免疫力的潜力.

主要方法:

德西塔用于诱导dSRNA在瘤细胞中的积累.
产生了含有dsRNA的细胞衍生纳米纤维 (NV).
使用lentiviral转染来将CD40L纳入NV表面,从而产生dsRNA@NV_CD40L.
在B16-OVA瘤模型中评估了dsRNA@NV_CD40L的疗效.

主要成果:

dsRNA@NV_CD40L通过激活树突细胞和通过CD40-CD40L相互作用调节巨细胞表型,有效地逆转了免疫抑制的TME.
CD40L的结合诱导了免疫性瘤细胞死亡.
在B16-OVA瘤模型中,dsRNA@NV_CD40L的使用引起了强烈的in situ癌症疫苗反应.

结论:

dsRNA@NV_CD40L代表了一个有前途的基于纳米纤维的疫苗策略.
这种方法解决了现有的瘤囊状疫苗的局限性,包括低免疫性和不充分的免疫反应激活.
工程NV疫苗通过有效调节免疫抑制TME,证明了改善癌症免疫治疗的潜力.

关键词:

在CD40L中,CD40L是CD40L.细胞免疫力细胞免疫力幽默性免疫力幽默性免疫力囊泡性疫苗可以使用.dsRNARNA 是一个

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.